[go: up one dir, main page]

NO20054798D0 - Prosessert fettpreparat for forebygging/bedring av livsstils-relaterte sykdommer - Google Patents

Prosessert fettpreparat for forebygging/bedring av livsstils-relaterte sykdommer

Info

Publication number
NO20054798D0
NO20054798D0 NO20054798A NO20054798A NO20054798D0 NO 20054798 D0 NO20054798 D0 NO 20054798D0 NO 20054798 A NO20054798 A NO 20054798A NO 20054798 A NO20054798 A NO 20054798A NO 20054798 D0 NO20054798 D0 NO 20054798D0
Authority
NO
Norway
Prior art keywords
lifestyle
prevention
improvement
related diseases
processed fat
Prior art date
Application number
NO20054798A
Other languages
English (en)
Other versions
NO20054798L (no
Inventor
Tatsumasa Mae
Hideyuki Kishida
Toshinori Ikehara
Naoki Arai
Original Assignee
Kaneka Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaneka Corp filed Critical Kaneka Corp
Publication of NO20054798D0 publication Critical patent/NO20054798D0/no
Publication of NO20054798L publication Critical patent/NO20054798L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Edible Oils And Fats (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO20054798A 2003-07-31 2005-10-18 Prosessert fettpreparat for forebygging/bedring av livsstils-relaterte sykdommer NO20054798L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003204275 2003-07-31
PCT/JP2004/010381 WO2005011672A1 (ja) 2003-07-31 2004-07-14 生活習慣病予防・改善用の油脂加工組成物

Publications (2)

Publication Number Publication Date
NO20054798D0 true NO20054798D0 (no) 2005-10-18
NO20054798L NO20054798L (no) 2006-01-31

Family

ID=34113638

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054798A NO20054798L (no) 2003-07-31 2005-10-18 Prosessert fettpreparat for forebygging/bedring av livsstils-relaterte sykdommer

Country Status (11)

Country Link
US (1) US20070098761A1 (no)
EP (1) EP1649854A1 (no)
JP (1) JPWO2005011672A1 (no)
KR (1) KR20060119706A (no)
CN (1) CN1777420A (no)
AU (1) AU2004261089A1 (no)
CA (1) CA2526589A1 (no)
NO (1) NO20054798L (no)
RU (1) RU2005126140A (no)
TW (1) TW200513194A (no)
WO (1) WO2005011672A1 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090041876A1 (en) * 2005-03-30 2009-02-12 Kaneka Corporation Oil/fat-containing composition for suppression of carcinogenesis
KR20070052211A (ko) * 2005-11-16 2007-05-21 주식회사 엠디바이오알파 글라브리딘을 유효성분으로 함유하는 질환 증후군 예방 및치료용 조성물
WO2007060992A1 (ja) * 2005-11-25 2007-05-31 Kaneka Corporation メタボリックシンドロームもしくはインスリン抵抗性症候群の予防または改善剤
TW200806306A (en) * 2006-02-24 2008-02-01 Kaneka Corp Oil-in-water emulsion composition containing licorice-derived polyphenol
TW200808333A (en) 2006-04-17 2008-02-16 Kaneka Corp Licorice polyphenol preparation
EP2163252A4 (en) * 2007-05-17 2012-01-11 Kaneka Corp COMPOSITION WITH POLYPHENOL FROM CANDY
US20090042813A1 (en) * 2007-08-10 2009-02-12 Sergey Michailovich Melnikov Hoodia extract oil compositions comprising medium chain triglycerides
WO2009025277A1 (ja) * 2007-08-22 2009-02-26 Kaneka Corporation 還元型補酵素ｑ10の製造方法、ならびに、その安定化方法
WO2011095095A1 (zh) * 2010-02-06 2011-08-11 桂林商源植物制品有限公司 一种含有醇溶性且非水溶性甘草提取物的药物组合物，及其药物制剂、制药用途、治疗方法和制备方法
JP2011231057A (ja) * 2010-04-28 2011-11-17 Kao Corp セラミド産生促進剤
CN102771673A (zh) * 2012-08-14 2012-11-14 江苏美迪森生物医药有限公司 一种构建代谢综合症动物模型的高脂纯化饲料及加工工艺
US20190152984A1 (en) 2016-06-29 2019-05-23 Glaceum, Inc. Optically active pyranochromenyl phenol derivative and pharmaceutical composition comprising same
CN111713503A (zh) * 2020-07-16 2020-09-29 江苏省中国科学院植物研究所 两种异黄酮类化合物在防治植物病害中的用途
EP4226920A4 (en) * 2020-10-07 2024-11-06 Kaneka Corporation Transthyretin tetramer stabilizer and agent for preventing or suppressing progression of transthyretin amyloidosis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2794433B2 (ja) * 1989-02-02 1998-09-03 丸善製薬株式会社 甘草疎水性フラボノイド製剤
JP4418550B2 (ja) * 1999-02-17 2010-02-17 丸善製薬株式会社 疎水性甘草エキス含有組成物
TWI329516B (en) * 2000-12-12 2010-09-01 Kaneka Corp Composition for preventing or ameliorating multiple risk factor syndromes and visceral fat-type obesity
CA2460134A1 (en) * 2001-10-11 2003-05-08 Kaneka Corporation Peroxisome proliferator activated receptor ligand and process for producing the same
US20060247310A1 (en) * 2002-03-04 2006-11-02 Hisami Shinohara Body temperature elevating agents
JP4191420B2 (ja) * 2002-03-26 2008-12-03 株式会社カネカ 甘草疎水性抽出物を含有してなる食用油脂組成物

Also Published As

Publication number Publication date
EP1649854A1 (en) 2006-04-26
NO20054798L (no) 2006-01-31
US20070098761A1 (en) 2007-05-03
WO2005011672A1 (ja) 2005-02-10
CN1777420A (zh) 2006-05-24
KR20060119706A (ko) 2006-11-24
JPWO2005011672A1 (ja) 2006-10-19
RU2005126140A (ru) 2006-02-10
TW200513194A (en) 2005-04-16
AU2004261089A1 (en) 2005-02-10
CA2526589A1 (en) 2005-02-10

Similar Documents

Publication Publication Date Title
HUS1500034I1 (hu) Indolidon-származékok fibrózisos betegségek kezelésére vagy megelõzésére
NO20033594L (no) Fenetanolamin-derivater for behandling av luftveissykdommer
CY2014019I2 (el) Παραγωγα φαιναιθανολαμινης για θεραπεια ασθενειων του αναπνευστικου
PT1556342E (pt) Derivado de fenetanolamina para o tratamento de doenças respiratórias
AP2006003671A0 (en) Sulfonamide derivatives for the treatment of diseases
IL184934A0 (en) 4-oxoquinazoline-3-yl-benzamide derivatives for the treatment of cytokine diseases
AP2006003669A0 (en) Sulfonamide derivatives for the treatment of diseases
IL176026A0 (en) Medical lipolysis of fat accumulations
NO20054798D0 (no) Prosessert fettpreparat for forebygging/bedring av livsstils-relaterte sykdommer
AP1959A (en) The use of N-arylhydrazine derivatives for combating pests
GB0329874D0 (en) Compounds useful for the treatment of diseases
GB0410399D0 (en) The treatment of respiratory disease
IL178815A0 (en) The treatment of respiratory disease
EP1781107A4 (en) PHYTOPHARMACEUTICAL COMPOSITIONS FOR PREVENTING AND / OR TREATING CARDIOVASCULAR DISEASES AND PROCESS FOR PREPARING THEM
PT1670482E (pt) Utilização de ciclesonida para o tratamento de doenças respiratórias
MY154346A (en) Dry fractionation of fat
PL1812797T3 (pl) Kompozycje i sposoby do leczenia chorób hiperproliferacyjnych i zapobiegania tym chorobom
GB0209254D0 (en) Preparation for the relief of disease
DE60326179D1 (de) Pflanzliche zubereitung zur behandlung von magengeschwüren
ITMI20022465A1 (it) Procedimento per la preparazione di pasta alimentare ad elevato
ZA200606780B (en) Compounds for the treatment of diseases
ITMI20041849A1 (it) Formulazioni farmaceutiche per l'integrazione alimentare di soggetti anoressici
GB0406387D0 (en) Sulfonamide derivatives for the treatment of diseases
GB0406388D0 (en) Sulfonamide derivatives for the treatment of diseases
IL176564A0 (en) Sulfonamide derivatives for the treatment of diseases

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application